Available Measures
Analyst Forecasts -
 Last Month Revisions
Fiscal Period MeanHighLowMedian# of Estimates#Up#DownMean % Change
AnnualDec 203.024.102.423.042103-0.30
AnnualDec 192.803.382.382.7526320.46
AnnualDec 182.473.102.252.4428321.17
QuarterlyMar 180.660.750.520.6723220.78
QuarterlyJun 180.600.670.460.6123311.35
QuarterlySep 180.580.700.510.5823321.99
QuarterlyDec 180.590.740.510.5723231.78
Long Term Growth -6.251.40-11.90-6.426000.00
Actuals -
  Reported EPSMean EstimateSurprise % Change
AnnualDec 174.013.834.57
AnnualDec 165.145.110.57
AnnualDec 155.425.44-0.38
QuarterlyDec 170.930.7621.66
QuarterlySep 171.001.04-3.96
QuarterlyJun 171.021.06-3.53
QuarterlyMar 171.061.032.81
P/E Ratios
PeriodP/E Ratio
FY07.14
FY16.32
FY25.85
EPS Growth Rates
Growth RatesCompanyIndustryInd. Relative
FY1/FY0-38.3012.120.550
FY2/FY113.0715.590.978
FY3/FY27.9715.240.937
Data Provided by Thomson Reuters

Disclaimer: Mean Earnings Estimates are calculated by First Call based on the earnings projections made by the analysts who cover Teva. Please note that any opinions, estimates or forecasts regarding TEVA's performance made by these analysts (and therefore the Mean Estimate numbers) are theirs alone and do not represent opinions, forecasts or predictions of Teva or its management. Teva does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.